SMNR (Semnur Pharmaceuticals) Common Stock: $0.02 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SMNR Semnur Pharmaceuticals Inc SMNR
8 GF Score
Price $0.72
View Full Analysis

What is Semnur Pharmaceuticals Common Stock?

Semnur Pharmaceuticals SMNR +0.70% 8 Common Stock is $0.02 Mil as of Mar. 2026. GuruFocus rates SMNR with a GF Score™ of 8/100.

Semnur Pharmaceuticals's quarterly common stock stayed the same from Sep. 2025 ($0.02 Mil) to Dec. 2025 ($0.02 Mil) and stayed the same from Dec. 2025 ($0.02 Mil) to Mar. 2026 ($0.02 Mil).

Semnur Pharmaceuticals's annual common stock increased from Dec. 2023 ($0.00 Mil) to Dec. 2024 ($0.02 Mil) and increased from Dec. 2024 ($0.02 Mil) to Dec. 2025 ($0.02 Mil).

Semnur Pharmaceuticals Common Stock Historical Data

* Premium members only.

The historical data trend for Semnur Pharmaceuticals's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Semnur Pharmaceuticals Common Stock Chart

Semnur Pharmaceuticals Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Common Stock
0.00 0.00 0.02 0.02

Semnur Pharmaceuticals Quarterly Data
Dec22 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.02 0.02 0.02
SMNR
8GF Score
Semnur Pharmaceuticals Inc SMNR
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Semnur Pharmaceuticals Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $0.02 Mil mean?
Semnur Pharmaceuticals (SMNR) has a Common Stock of $0.02 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Semnur Pharmaceuticals and its competitors.
Is Semnur Pharmaceuticals' Common Stock too high?
Semnur Pharmaceuticals' current Common Stock is $0.02 Mil. Overall, Semnur Pharmaceuticals has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Semnur Pharmaceuticals' Common Stock compare to CNTB and ENLV?
Semnur Pharmaceuticals' Common Stock of $0.02 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Semnur Pharmaceuticals and its competitors. Semnur Pharmaceuticals's current Common Stock is $0.02 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Semnur Pharmaceuticals stock overvalued right now?
Semnur Pharmaceuticals (SMNR) has a current Common Stock of $0.02 Mil. The current Common Stock is $0.02 Mil. Semnur Pharmaceuticals' overall GF Score™ is 8/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Semnur Pharmaceuticals (SMNR), the current Common Stock is $0.02 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Semnur Pharmaceuticals Business Description

Address 960 San Antonio Road, Palo Alto, CA, USA, 94303
Semnur Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its main product candidate, SP-102 (10 mg, dexamethasone sodium phosphate viscous gel), is being developed as a non-opioid novel injectable corticosteroid gel formulation for patients with moderate to severe LRP (also known as sciatica), containing no preservatives, surfactants, solvents, or particulates.
8GF Score

Get the complete analysis for SMNR

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.72
Price